Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-08-09

Clinical Trial Update: The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

View source ↗

Summary

An update on the molecular biology of paroxysmal nocturnal hemoglobinuria (PNH) from a completed University of Utah clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Utah | Conditions: Hemoglobinuria, Paroxysmal | Status: COMPLETED